The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1. (Q53443415)

14 May 2018

title

The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1. (English)

1 reference

14 May 2018

1 reference

14 May 2018

Jens Juul Holst

series ordinal

1 reference

14 May 2018

Simon Veedfald

0 references

Carolyn F Deacon

0 references

Tina Vilsbøll

1 reference

14 May 2018

Filip K Knop

1 reference

14 May 2018

Astrid Plamboeck

series ordinal

object named as

Astrid Plamboeck

1 reference

14 May 2018

publication date

1 July 2015

1 reference

14 May 2018

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

14 May 2018

volume

309

1 reference

14 May 2018

issue

1 reference

14 May 2018

page(s)

R544-51

1 reference

14 May 2018

Autonomic regulation of islet hormone secretion--implications for health and disease

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effect of Atropine on Vagal Release of Gastrin and Pancreatic Polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Evidence that glicentin contains the entire sequence of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Autonomic nervous control of the endocrine secretion from the isolated, perfused pig pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Gastrointestinal somatostatin: distribution, secretion and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Innervation patterns of autonomic axons in the human endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effects of muscarinic blockade on insulin secretion and on glucose-induced thermogenesis in lean and obese human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Pancreatic polypeptide: a unique model for vagal control of endocrine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Efficacy and safety of incretin based therapies: clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

On the accuracy of radioimmunological determination of somatostatin in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Nervous control of pancreatic endocrine secretion in pigs V. Influence of the sympathetic nervous system on the pancreatic secretion of insulin and glucagon, and on the insulin and glucagon response to vagal stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Nervous control of pancreatic endocrine secretion in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

The effect of gastrin-releasing peptide on the endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00123.2015

10.1152/AJPREGU.00123.2015

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018